{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:08:07Z","timestamp":1792480087021,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10549-018-5053-y","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T08:30:31Z","timestamp":1543221031000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with Trastuzumab-based chemotherapy"],"prefix":"10.1007","volume":"174","author":[{"given":"Mohamed","family":"Abouegylah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior Z.","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Alm El-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Niemierko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Elebrashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha K.","family":"Edgington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla","family":"Remillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Naoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda E.","family":"Sayegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Farouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelsalam A.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2211-9355","authenticated-orcid":false,"given":"Alphonse G.","family":"Taghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"5053_CR1","first-page":"7","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A (2017) Cancer, statistics. CA: Cancer J Clin 2017 67:7","journal-title":"CA: Cancer J Clin"},{"key":"5053_CR2","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1056\/NEJMoa050518","volume":"353 17","author":"DA Berry","year":"2005","unstructured":"Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353 17:1784\u20131792","journal-title":"N Engl J Med"},{"key":"5053_CR3","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707\u20131716","journal-title":"Lancet"},{"issue":"9503","key":"5053_CR4","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"M Clarke","year":"2005","unstructured":"Clarke M, Collins R, Darby S et al (2005) Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087\u20132106","journal-title":"Lancet"},{"key":"5053_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.radonc.2017.03.012","volume":"123","author":"JC Rehammar","year":"2017","unstructured":"Rehammar JC, Jensen MB, McGale P et al (2017) Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977\u20132005. Radiother Oncol 123:299\u2013305","journal-title":"Radiother Oncol"},{"key":"5053_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fonc.2015.00039","volume":"5","author":"NK Taunk","year":"2015","unstructured":"Taunk NK, Haffty BG, Kostis JB, Goyal S (2015) Radiation-induced heart disease: pathologic abnormalities and putative mechanisms. Front Oncol 5:39","journal-title":"Front Oncol"},{"key":"5053_CR7","doi-asserted-by":"crossref","unstructured":"Taylor CW, Nisbet A, McGale P et al (2007) Cardiac exposures in breast cancer radiotherapy: 1950s\u20131990s Int J Radiat Oncol Biol Phys 69:1484\u2013 1495","DOI":"10.1016\/j.ijrobp.2007.05.034"},{"key":"5053_CR8","doi-asserted-by":"crossref","unstructured":"Romond EH, Jeong JH, Rastogi P et al (2012) Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol 30:3792\u20133799","DOI":"10.1200\/JCO.2011.40.0010"},{"key":"5053_CR9","doi-asserted-by":"crossref","unstructured":"Ewer MS, Vooletich MT, Durand JB et al (2005) Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment. J Clin Oncol 23:7820\u20137826","DOI":"10.1200\/JCO.2005.13.300"},{"key":"5053_CR10","unstructured":"https:\/\/www.rtog.org\/LinkClick.aspx?fileticket=eVB451KQ83M%3d&tabid=429"},{"issue":"1","key":"5053_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1118\/1.598063","volume":"24","author":"A Niemierko","year":"1997","unstructured":"Niemierko A (1997) Reporting and analyzing dose distributions: a concept of Equivalent Uniform Dose (EUD). Med Phys 24(1):17\u201326","journal-title":"Med Phys"},{"key":"5053_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejca.2010.08.013","volume":"47","author":"L Caussa","year":"2011","unstructured":"Caussa L, Kirova YM, Gault N et al (2011) The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: a single-institution study. Eur J Cancer Oxf Engl 47:65\u201373","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"25","key":"5053_CR13","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1200\/JCO.2005.04.9551","volume":"24","author":"V Guarneri","year":"2006","unstructured":"Guarneri V, Lenihan DJ, Valero V et al (2006) Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience. J Clin Oncol 24(25):4107\u20134115","journal-title":"J Clin Oncol"},{"key":"5053_CR14","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1200\/JCO.2008.17.9549","volume":"27","author":"MY Halyard","year":"2009","unstructured":"Halyard MY, Pisansky TM, Dueck AC et al (2009) Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol 27:2638\u20132644","journal-title":"J Clin Oncol"},{"key":"5053_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.radonc.2008.09.003","volume":"90","author":"R Shaffer","year":"2009","unstructured":"Shaffer R, Tyldesley S, Rolles M et al (2009) Acute cardiotoxicity with concurrent trastuzumab and radiotherapy including internal mammary chain nodes: a retrospective single-institution study. Radiother Oncol 90:122\u2013126","journal-title":"Radiother Oncol"},{"key":"5053_CR16","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.18632\/oncotarget.6053","volume":"7","author":"L Cao","year":"2016","unstructured":"Cao L, Cai G, Chang C et al (2016) Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab. Oncotarget 7:1042\u20131054","journal-title":"Oncotarget"},{"key":"5053_CR17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGalle P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987\u2013998","journal-title":"N Engl J Med"},{"key":"5053_CR18","doi-asserted-by":"crossref","first-page":"e005633","DOI":"10.1161\/JAHA.117.005633","volume":"6","author":"YJ Cheng","year":"2017","unstructured":"Cheng YJ, Nie XY, Ji CC et al (2017) Long-term cardiovascular risk after radiotherapy in women with breast cancer. J Am Heart Assoc 6:e005633","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"5053_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ijrobp.2017.06.018","volume":"99","author":"SP Wu","year":"2017","unstructured":"Wu SP, Tam M, Vega RM, et al (2017) Effect of breast irradiation on cardiac disease in women enrolled in BCIRG-001 at 10-year follow-up. Int J Radiat Oncol Biol Phys 99(3):541\u2013548","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-5053-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-5053-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-5053-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T22:01:49Z","timestamp":1662501709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-5053-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["5053"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-5053-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"9 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that he\/she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}